Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

OBJECTIVE: Clinical and laboratory biomarkers to predict the severity of coronavirus disease 2019 (COVID-19) are essential in this pandemic situation of which resource allocation must be urgently prepared especially in the context of respiratory support readiness. Lymphocyte count has been a marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ian, Pranata, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245646/
https://www.ncbi.nlm.nih.gov/pubmed/32483488
http://dx.doi.org/10.1186/s40560-020-00453-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245646/
https://www.ncbi.nlm.nih.gov/pubmed/32483488
http://dx.doi.org/10.1186/s40560-020-00453-4

Ejemplares similares